Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

1.7K
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
1.7K
Anthelminthic Agents01:15

Anthelminthic Agents

103
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
103
Bioreactor Controls-III01:22

Bioreactor Controls-III

67
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
67

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Administration of Topical NorLeu<sup>3</sup>Angiotensin(1-7) Minimizes Fibrotic Corneal Healing in Stellate Wound: A 28-Day Study.

International journal of molecular sciences·2026
Same author

A perspective: PLA2G4A as drug target for vascular inflammation in Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Evidence for cPLA2 activation in Alzheimer's disease synaptic pathology.

Acta neuropathologica communications·2026
Same author

Development of potent, selective cPLA<sub>2</sub> inhibitors for targeting neuroinflammation in Alzheimer's disease and other neurodegenerative disorders.

npj drug discovery·2026
Same author

Telmisartan reduces systemic inflammation and alters the renin-angiotensin system in mild COVID-19.

Scientific reports·2025
Same author

Thiamine Deficiency and Neuroinflammation Are Important Contributors to Alcohol Use Disorder.

Pathophysiology : the official journal of the International Society for Pathophysiology·2025

Related Experiment Video

Updated: May 3, 2026

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
05:12

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder

Published on: June 23, 2023

1.9K

Avermectins differentially affect ethanol intake and receptor function: implications for developing new therapeutics

Liana Asatryan1, Megan M Yardley2, Sheraz Khoja2

  • 1Titus Family Department of Clinical Pharmacy and Pharmaceutical Economics and Policy, School of Pharmacy, 1985 Zonal Avenue, Los Angeles, CA 90033, USA.

The International Journal of Neuropsychopharmacology
|January 24, 2014
PubMed
Summary

Ivermectin and abamectin reduce alcohol intake in mice by modulating specific ion channels. Chemical structure and receptor effects, not just brain penetration, are key for avermectins treating alcohol use disorders.

More Related Videos

An Inexpensive, Scalable Behavioral Assay for Measuring Ethanol Sedation Sensitivity and Rapid Tolerance in Drosophila
07:28

An Inexpensive, Scalable Behavioral Assay for Measuring Ethanol Sedation Sensitivity and Rapid Tolerance in Drosophila

Published on: April 15, 2015

9.9K
An Assay for Measuring the Effects of Ethanol on the Locomotion Speed of Caenorhabditis elegans
10:35

An Assay for Measuring the Effects of Ethanol on the Locomotion Speed of Caenorhabditis elegans

Published on: April 9, 2015

8.3K

Related Experiment Videos

Last Updated: May 3, 2026

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
05:12

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder

Published on: June 23, 2023

1.9K
An Inexpensive, Scalable Behavioral Assay for Measuring Ethanol Sedation Sensitivity and Rapid Tolerance in Drosophila
07:28

An Inexpensive, Scalable Behavioral Assay for Measuring Ethanol Sedation Sensitivity and Rapid Tolerance in Drosophila

Published on: April 15, 2015

9.9K
An Assay for Measuring the Effects of Ethanol on the Locomotion Speed of Caenorhabditis elegans
10:35

An Assay for Measuring the Effects of Ethanol on the Locomotion Speed of Caenorhabditis elegans

Published on: April 9, 2015

8.3K

Area of Science:

  • Neuropharmacology
  • Drug Discovery

Background:

  • Alcohol use disorders (AUDs) represent a significant public health challenge.
  • Avermectins, including ivermectin (IVM), show potential as novel therapeutics for AUDs.
  • Previous research indicated IVM reduces ethanol intake by modulating ligand-gated ion channels.

Purpose of the Study:

  • To investigate the potential of IVM and related avermectins (abamectin, selamectin) as pharmacotherapeutics for AUDs.
  • To determine if structural modifications enhancing receptor modulation and brain concentration improve anti-alcohol efficacy.
  • To explore the role of GABAARs and P2X4Rs in the anti-alcohol effects of avermectins.

Main Methods:

  • Comparison of ethanol intake in mice treated with IVM, abamectin (ABM), and selamectin (SEL).
  • Assessment of avermectin modulation of GABAARs and P2X4Rs in Xenopus oocytes.
  • Measurement of brain penetration of IVM, ABM, and SEL in mice.

Main Results:

  • IVM and ABM significantly reduced ethanol intake in mice.
  • IVM and ABM antagonized ethanol's inhibitory effects on P2X4R function.
  • SEL did not reduce ethanol intake, despite higher brain concentrations, suggesting brain penetration is insufficient alone.
  • All tested avermectins potentiated GABAAR function.

Conclusions:

  • Avermectin efficacy in reducing ethanol intake is linked to their chemical structure and specific effects on receptor function, particularly P2X4R antagonism.
  • Modulation of P2X4R function by avermectins is a strong predictor of their potential to reduce alcohol consumption.
  • Avermectins represent a promising platform for developing new drugs to prevent and treat AUDs.